Loading clinical trials...
Loading clinical trials...
Study Protocol for a Randomized Controlled Trial of Neurofeedback Mindfulness in Chronic Migraines
As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Start Date
December 1, 2024
Primary Completion Date
December 1, 2025
Completion Date
June 1, 2026
Last Updated
April 2, 2024
135
ESTIMATED participants
Neurofeedback Mindfulness
BEHAVIORAL
Attention Task
BEHAVIORAL
Lead Sponsor
University of Saskatchewan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05464212